ArticleNature medicine2022

A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma.

Emmanuel Bachy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.